Correlation Between SAB Biotherapeutics and UroGen Pharma
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and UroGen Pharma, you can compare the effects of market volatilities on SAB Biotherapeutics and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and UroGen Pharma.
Diversification Opportunities for SAB Biotherapeutics and UroGen Pharma
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between SAB and UroGen is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and UroGen Pharma go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and UroGen Pharma
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 16.64 times more return on investment than UroGen Pharma. However, SAB Biotherapeutics is 16.64 times more volatile than UroGen Pharma. It trades about 0.11 of its potential returns per unit of risk. UroGen Pharma is currently generating about 0.04 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on September 4, 2024 and sell it today you would earn a total of 0.17 from holding SAB Biotherapeutics or generate 3.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 75.15% |
| Values | Daily Returns |
SAB Biotherapeutics vs. UroGen Pharma
Performance |
| Timeline |
| SAB Biotherapeutics |
| UroGen Pharma |
SAB Biotherapeutics and UroGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and UroGen Pharma
The main advantage of trading using opposite SAB Biotherapeutics and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| UroGen Pharma vs. Eliem Therapeutics | UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |